<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(6)</volume><submitter>Doan TN</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>To date, there is no conclusive evidence that transcutaneous neuromuscular electrical stimulation (TNMES) benefits patients with post-stroke dysphagia (PSD). In addition, the optimal TNMES electrode placement has not been well-established. This systematic review and meta-analysis were conducted to investigate these two research gaps.&lt;h4>Methods&lt;/h4>Five major databases were systematically searched for randomized controlled trials (RCTs) through January 2022. Effect sizes were computed using Hedges' g statistic, which were then entered into the random-effects model to obtain pooled effect estimates.&lt;h4>Results&lt;/h4>Twenty-four RCTs met the eligibility criteria. On the improvement of swallowing function, TNMES alone was not superior to conventional swallowing therapies (CSTs); combined therapy of TNMES and CSTs significantly surpassed CSTs alone (standardized mean difference (SMD) = 0.91, 95% confidence interval (95% CI): 0.68 to 1.14, &lt;i>p&lt;/i> &amp;lt; 0.0001; I&lt;sup>2&lt;/sup> = 63%). Moreover, significant pooled effect sizes were observed in subgroups with horizontal electrode placement above the hyoid bone (SMD = 0.94, 95% CI: 0.72 to 1.16; I&lt;sup>2&lt;/sup> = 0%) and horizontal electrode placement just above and below the hyoid bone (SMD = 0.87, 95% CI: 0.59 to 1.14; I&lt;sup>2&lt;/sup> = 0%). The largest pooled effect size was observed in the subgroup that individualized electrode placement according to dysphagia evaluation (SMD = 1.65, 95% CI: 0.38 to 2.91; I&lt;sup>2&lt;/sup> = 90%).&lt;h4>Conclusion&lt;/h4>TNMES should be used in combination with CSTs for PSD. Horizontal electrode placement should target suprahyoid muscles or both suprahyoid and thyrohyoid muscles.</pubmed_abstract><journal>Life (Basel, Switzerland)</journal><pagination>875</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9225155</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Therapeutic Effect and Optimal Electrode Placement of Transcutaneous Neuromuscular Electrical Stimulation in Patients with Post-Stroke Dysphagia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.</pubmed_title><pmcid>PMC9225155</pmcid><pubmed_authors>Tran TTQ</pubmed_authors><pubmed_authors>Chang FC</pubmed_authors><pubmed_authors>Wang LH</pubmed_authors><pubmed_authors>Doan TN</pubmed_authors><pubmed_authors>Chou LW</pubmed_authors><pubmed_authors>Ho WC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Therapeutic Effect and Optimal Electrode Placement of Transcutaneous Neuromuscular Electrical Stimulation in Patients with Post-Stroke Dysphagia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.</name><description>&lt;h4>Background&lt;/h4>To date, there is no conclusive evidence that transcutaneous neuromuscular electrical stimulation (TNMES) benefits patients with post-stroke dysphagia (PSD). In addition, the optimal TNMES electrode placement has not been well-established. This systematic review and meta-analysis were conducted to investigate these two research gaps.&lt;h4>Methods&lt;/h4>Five major databases were systematically searched for randomized controlled trials (RCTs) through January 2022. Effect sizes were computed using Hedges' g statistic, which were then entered into the random-effects model to obtain pooled effect estimates.&lt;h4>Results&lt;/h4>Twenty-four RCTs met the eligibility criteria. On the improvement of swallowing function, TNMES alone was not superior to conventional swallowing therapies (CSTs); combined therapy of TNMES and CSTs significantly surpassed CSTs alone (standardized mean difference (SMD) = 0.91, 95% confidence interval (95% CI): 0.68 to 1.14, &lt;i>p&lt;/i> &amp;lt; 0.0001; I&lt;sup>2&lt;/sup> = 63%). Moreover, significant pooled effect sizes were observed in subgroups with horizontal electrode placement above the hyoid bone (SMD = 0.94, 95% CI: 0.72 to 1.16; I&lt;sup>2&lt;/sup> = 0%) and horizontal electrode placement just above and below the hyoid bone (SMD = 0.87, 95% CI: 0.59 to 1.14; I&lt;sup>2&lt;/sup> = 0%). The largest pooled effect size was observed in the subgroup that individualized electrode placement according to dysphagia evaluation (SMD = 1.65, 95% CI: 0.38 to 2.91; I&lt;sup>2&lt;/sup> = 90%).&lt;h4>Conclusion&lt;/h4>TNMES should be used in combination with CSTs for PSD. Horizontal electrode placement should target suprahyoid muscles or both suprahyoid and thyrohyoid muscles.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2024-12-03T18:41:06.53Z</modification><creation>2024-12-03T18:41:06.53Z</creation></dates><accession>S-EPMC9225155</accession><cross_references><pubmed>35743906</pubmed><doi>10.3390/life12060875</doi></cross_references></HashMap>